The protective effect and immunomodulatory ability of orally administrated Lacticaseibacillus rhamnosus GG against Mycoplasma pneumoniae infection in BALB/c mice
Authors:
Open Access
- 25 October 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (10) , e0312318
Abstract
Mycoplasma pneumoniae represents one of the significant etiologies of community-acquired pneumonia in pediatric patients. However, clinical treatment of M. pneumoniae infection in children has encountered challenges due to the escalating resistance to quinolones. Numerous studies have highlighted the potential of probiotic lactobacillus administration in boosting immune responses to bacterial and viral respiratory infections. In this study, the protective efficacy of pre-oral administration of Lacticaseibacillus rhamnosus GG (LGG), Limosilactobacillus reuteri F275, Lactiplantibacillus plantarum NCIMB 8826, L. plantarum S1 or L. plantarum S2 was evaluated in the BALB/c mice model; it was observed that among these five strains of lactobacillus, the supplementation of LGG exhibited the most significant protective effect against M. pneumoniae infection. Moreover, when administered orally, both live LGG and heat-inactivated LGG have demonstrated efficacy in reducing the burden of M. pneumoniae in the lungs and alleviating pulmonary inflammation. Oral supplementation with LGG resulted in the inhibition of neutrophil recruitment into the lungs and increased recruitment of alveolar macrophages in M. pneumoniae-infected mice. Additionally, LGG supplementation led to increased production of IL-10 and secretory IgA (sIgA), while suppressing the levels of IL-1β, IL-6, IL-17A, and TNF-α in the lungs of mice infected with M. pneumoniae. The data suggests that supplementation with LGG can modulate immune responses, decrease pathogen load, and alleviate inflammatory injury in the lungs of M. pneumoniae-infected mice.Keywords
Funding Information
- National Natural Science Foundation of China (No. 31970177)
- Key Research and Development Program of Hunan Province of China (D202310008129)
This publication has 61 references indexed in Scilit:
- Effect of Lactobacillus rhamnosus GG on rBet v1 and rMal d1 specific IgA in the saliva of patients with birch pollen allergyAnnals of Allergy, Asthma & Immunology, 2008
- [Bacteria of Lactobacillus casei group: characterization, viability as probiotic in food products and their importance for human health].2007
- [Effect of Lactobacillus casei on the incidence of infectious conditions in children].2006
- An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumoniaInternational Journal of Infectious Diseases, 2005
- Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γNature Immunology, 2005
- Mycoplasma pneumoniae Induces Host-Dependent Pulmonary Inflammation and Airway Obstruction in MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2005
- Effect of a Probiotic Infant Formula on Infections in Child Care Centers: Comparison of Two Probiotic AgentsPediatrics, 2005
- Mycoplasma pneumoniae and Asthma in ChildrenClinical Infectious Diseases, 2004
- Effect of Lactobacillus casei and Yogurt Administration on Prevention of Pseudomonas aeruginosa Infection in Young MiceJournal of Food Protection, 2001
- Taxonomy and important features of probiotic microorganisms in food and nutritionThe American Journal of Clinical Nutrition, 2001